DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Dec 15, 2023 | Option Exercise | $88.60 | 8,713 | 771,972 | 70,481 | Dec 19, 2023, 07:34 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Dec 18, 2023 | Sale | $86.39 | 10,493 | 906,491 | 68,844 | Dec 19, 2023, 07:34 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Dec 19, 2023 | Sale | $86.01 | 1,663 | 143,038 | 58,325 | Dec 19, 2023, 07:34 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Jul 12, 2023 | Option Exercise | $75.66 | 42,000 | 3,177,720 | 77,730 | Jul 14, 2023, 04:34 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | May 08, 2023 | Sale | $66.72 | 30,000 | 2,001,709 | 71,374 | May 10, 2023, 04:51 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Feb 03, 2023 | Sale | $65.25 | 24,000 | 1,566,000 | 70,787 | Feb 07, 2023, 09:08 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, Gen. Counsel & Secretary | Feb 07, 2023 | Sale | $83.65 | 2,413 | 201,836 | 56,374 | Feb 07, 2023, 09:08 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 20, 2022 | Sale | $68.09 | 1,638 | 111,531 | 58,787 | Dec 22, 2022, 04:12 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2022 | Option Exercise | $73.17 | 2,510 | 183,657 | 49,372 | Dec 19, 2022, 09:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2022 | Option Exercise | $70.91 | 5,908 | 418,926 | 69,441 | Dec 19, 2022, 09:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 19, 2022 | Option Exercise | $70.07 | 6,682 | 468,239 | 65,495 | Dec 19, 2022, 09:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 09, 2022 | Sale | $77.23 | 1,798 | 138,860 | 51,601 | Feb 09, 2022, 08:36 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 20, 2021 | Sale | $90.69 | 1,638 | 148,550 | 53,399 | Dec 20, 2021, 08:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2021 | Sale | $91.07 | 3,275 | 298,257 | 56,700 | Dec 20, 2021, 08:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2020 | Sale | $91.46 | 3,401 | 311,051 | 60,076 | Dec 16, 2021, 09:25 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2021 | Option Exercise | $90.55 | 3,506 | 317,468 | 46,956 | Dec 16, 2021, 09:25 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Mar 01, 2021 | Sale | $72.75 | 26,000 | 1,891,500 | 63,010 | Mar 03, 2021, 04:12 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 16, 2021 | Option Exercise | $70.25 | 26,000 | 1,826,500 | 63,010 | Feb 17, 2021, 04:40 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 05, 2021 | Sale | $69.26 | 53,663 | 3,716,825 | 73,128 | Feb 08, 2021, 09:19 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2020 | Option Exercise | $91.03 | 1,612 | 146,740 | 53,311 | Dec 21, 2020, 05:51 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 18, 2020 | Sale | $91.96 | 1,638 | 150,629 | 51,673 | Dec 21, 2020, 05:51 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2020 | Option Exercise | $90.86 | 3,348 | 304,199 | 45,690 | Dec 17, 2020, 07:27 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2020 | Sale | $91.16 | 5,039 | 459,371 | 58,325 | Dec 17, 2020, 07:27 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Nov 03, 2020 | Sale | $61.57 | 50,000 | 3,078,508 | 72,456 | Nov 05, 2020, 04:30 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Nov 02, 2020 | Sale | $59.49 | 50,000 | 2,974,507 | 74,038 | Nov 03, 2020, 04:35 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 19, 2020 | Sale | $57.99 | 40,000 | 2,319,600 | 68,651 | Feb 20, 2020, 04:35 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 06, 2020 | Option Exercise | $55.20 | 73,230 | 4,042,056 | 78,472 | Feb 10, 2020, 08:01 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 05, 2020 | Option Exercise | $55.64 | 93,385 | 5,196,374 | 86,827 | Feb 06, 2020, 08:31 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2019 | Option Exercise | $68.40 | 1,612 | 110,261 | 55,266 | Dec 18, 2019, 09:38 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2019 | Option Exercise | $67.75 | 4,898 | 331,840 | 43,678 | Dec 18, 2019, 09:38 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jul 31, 2019 | Option Exercise | $50.33 | 100,000 | 5,032,500 | 78,366 | Aug 02, 2019, 07:18 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 01, 2019 | Option Exercise | $52.13 | 15,000 | 781,968 | 54,616 | Aug 02, 2019, 07:18 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 22, 2019 | Option Exercise | $49.08 | 10,126 | 496,933 | 53,242 | Feb 25, 2019, 07:08 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 21, 2019 | Option Exercise | $49.55 | 46,638 | 2,310,872 | 67,697 | Feb 25, 2019, 07:08 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2018 | Option Exercise | $66.17 | 6,387 | 422,628 | 41,669 | Dec 19, 2018, 08:03 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 18, 2018 | Sale | $64.55 | 4,726 | 305,063 | 50,343 | Dec 19, 2018, 08:03 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 23, 2018 | Sale | $50.24 | 20,000 | 1,004,900 | 58,056 | Aug 27, 2018, 04:22 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 26, 2018 | Sale | $47.74 | 20,000 | 954,900 | 57,566 | Feb 27, 2018, 08:49 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 07, 2018 | Option Exercise | $46.21 | 98,446 | 4,549,002 | 88,785 | Feb 09, 2018, 08:23 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 08, 2018 | Sale | $45.89 | 63,108 | 2,896,180 | 79,120 | Feb 09, 2018, 08:23 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 12, 2018 | Option Exercise | $46.62 | 20,000 | 932,400 | 59,120 | Jan 16, 2018, 06:35 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2017 | Option Exercise | $60.99 | 4,894 | 298,485 | 41,531 | Dec 19, 2017, 08:57 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 18, 2017 | Option Exercise | $62.48 | 4,746 | 296,532 | 53,714 | Dec 19, 2017, 08:57 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 19, 2017 | Sale | $62.22 | 1,665 | 103,591 | 49,120 | Dec 19, 2017, 08:57 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Oct 18, 2017 | Sale | $44.12 | 14,000 | 617,682 | 52,935 | Oct 20, 2017, 04:30 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Sep 13, 2017 | Sale | $42.24 | 28,000 | 1,182,860 | 59,935 | Sep 15, 2017, 04:35 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Mar 29, 2017 | Option Exercise | $40.37 | 12,000 | 484,440 | 51,935 | Mar 31, 2017, 04:52 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Mar 01, 2017 | Option Exercise | $39.12 | 12,000 | 469,440 | 51,935 | Mar 02, 2017, 08:45 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 30, 2017 | Option Exercise | $38.96 | 22,409 | 873,099 | 55,935 | Feb 01, 2017, 05:03 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 21, 2016 | Option Exercise | $46.30 | 1,879 | 86,998 | 49,463 | Dec 22, 2016, 07:31 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 22, 2016 | Sale | $46.07 | 1,119 | 51,548 | 48,344 | Dec 22, 2016, 07:31 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2016 | Option Exercise | $45.50 | 2,632 | 119,756 | 56,512 | Dec 19, 2016, 07:16 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2016 | Sale | $45.77 | 4,088 | 187,127 | 54,695 | Dec 19, 2016, 07:16 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 19, 2016 | Sale | $45.96 | 1,082 | 49,727 | 51,342 | Dec 19, 2016, 07:16 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 10, 2016 | Option Exercise | $49.73 | 3,705 | 184,250 | 52,491 | Aug 11, 2016, 07:58 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 11, 2016 | Sale | $49.52 | 6,152 | 304,629 | 46,339 | Aug 11, 2016, 07:58 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 21, 2015 | Option Exercise | $33.74 | 1,879 | 63,397 | 56,196 | Dec 22, 2015, 06:49 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2015 | Option Exercise | $33.15 | 3,821 | 126,666 | 59,892 | Dec 17, 2015, 08:33 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2015 | Option Exercise | $34.01 | 1,817 | 61,796 | 58,075 | Dec 17, 2015, 08:33 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Oct 26, 2015 | Sale | $34.66 | 4,500 | 155,953 | 51,213 | Oct 27, 2015, 07:17 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 10, 2015 | Option Exercise | $34.69 | 3,705 | 128,526 | 58,789 | Aug 12, 2015, 07:50 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Aug 12, 2015 | Sale | $33.68 | 3,076 | 103,587 | 55,713 | Aug 12, 2015, 07:50 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 22, 2015 | Sale | $38.67 | 1,291 | 49,917 | 63,360 | Jan 22, 2015, 08:30 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 20, 2015 | Option Exercise | $41.96 | 1,767 | 74,143 | 63,760 | Jan 22, 2015, 08:30 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 24, 2014 | Sale | $43.93 | 907 | 39,846 | 65,527 | Dec 29, 2014, 04:11 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 22, 2014 | Option Exercise | $44.08 | 1,785 | 78,683 | 66,434 | Dec 23, 2014, 07:18 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2014 | Sale | $42.46 | 1,529 | 64,920 | 69,305 | Dec 18, 2014, 08:05 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 18, 2014 | Sale | $43.54 | 1,086 | 47,285 | 68,219 | Dec 18, 2014, 08:05 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2014 | Option Exercise | $42.49 | 1,309 | 55,619 | 70,834 | Dec 18, 2014, 08:05 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 15, 2014 | Option Exercise | $42.98 | 1,842 | 79,169 | 72,143 | Dec 17, 2014, 05:48 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 23, 2014 | Sale | $40.41 | 1,954 | 78,961 | 61,978 | Jan 24, 2014, 05:11 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 21, 2014 | Option Exercise | $40.50 | 1,744 | 70,632 | 63,932 | Jan 22, 2014, 06:31 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 26, 2013 | Sale | $38.61 | 1,685 | 65,058 | 65,676 | Dec 30, 2013, 08:12 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 23, 2013 | Option Exercise | $38.56 | 1,353 | 52,172 | 67,361 | Dec 26, 2013, 07:38 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 16, 2013 | Option Exercise | $37.35 | 1,842 | 68,799 | 71,007 | Dec 18, 2013, 08:36 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 18, 2013 | Sale | $37.37 | 2,293 | 85,689 | 68,714 | Dec 18, 2013, 08:36 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 01, 2013 | Sale | $32.32 | 4,219 | 136,358 | 58,922 | Feb 05, 2013, 05:13 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 18, 2013 | Option Exercise | $30.42 | 1,825 | 55,517 | 63,141 | Jan 22, 2013, 08:27 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Dec 17, 2012 | Option Exercise | $35.34 | 1,798 | 63,541 | 50,566 | Dec 19, 2012, 05:56 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Feb 07, 2012 | Sale | $37.48 | 2,608 | 97,748 | 32,650 | Feb 08, 2012, 06:08 PM |
DLB | | Dolby Laboratories, Inc. | SHERMAN MARK ANDREW | EVP, GEN. COUN. & SECRTY | Jan 18, 2012 | Option Exercise | $33.05 | 1,742 | 57,573 | 35,258 | Jan 20, 2012, 05:50 PM |